2m 2m 2m 2m 2m 2m 2m
Liquidia (LQDA)
NASDAQ
$39.36+$0.49 (+1.27%)
Price as of Oct 22, 2026 7:59 PM EDT- $3.5BMarket Cap
- 73.95%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Liquidia (LQDA)
$39.36+$0.49 (+1.27%)
LQDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $38.86 | ||
Change | +$2.51 (+6.91%) | ||
Open | $36.65 | ||
High | $39.20 | ||
Low | $36.51 | ||
Previous Close | $36.35 | ||
Volume | 3,884,718 | ||
30-Day Average Volume | 6,322,130 | ||
1-Week Change | 14.50% | ||
1-Month Change | -41.50% | ||
1-Year Change | 73.95% | ||
3-Year Change | 530.33% | ||
5-Year Change | 944.62% | ||
Fundamentals | |||
Shares Outstanding | 89.5M | ||
Total Assets | $521.9M | ||
Market Cap | $3.5B | ||
Enterprise Value | $3.2B | ||
Period: QTR TTM FY | |||
Revenue | $170.4M | ||
Net Income | $74.7M | ||
Free Cash Flow | $69.0M | ||
EBIT | $81.7M | ||
EBITDA | $82.1M | ||
Net Working Capital | $248.4M | ||
EPS | $0.74 | ||
Enterprise Value/EBITDA | 39 | ||
Enterprise Value/Revenue | 19 | ||
P/B | 18 | ||
P/E | 53 | ||
PEG | 1 | ||
Price/Free Cash Flow | 50 | ||
Price/Operating Cash Flow | 43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue